Easily Send & Share Press Releases
If you make changes to this saved search, you'll find the original and new searches in your account.
Your search filters:
Narrow by:
Show Top 5
Show All
Show More
Showing 1-10 of about 248 articles.
Immunomedics, Inc.
Immunomedics Announces Third Quarter Fiscal 2013 Results and Clinical Program Developments
MORRIS PLAINS, N.J., May 8, 2013 (GLOBE NEWSWIRE) --
about 17 days ago
Immunomedics Announces Three New Patent Awards
MORRIS PLAINS, N.J., May 7, 2013 (GLOBE NEWSWIRE) --
about 18 days ago
Immunomedics Announces Conference Call and Webcast for Third Quarter Fiscal 2013 Financial Results
MORRIS PLAINS, N.J., April 25, 2013 (GLOBE NEWSWIRE) --
about 30 days ago
Immunomedics Develops T-Cell Redirecting Bispecific Antibodies as Potential Therapeutics for Solid and Liquid Tumors
WASHINGTON, April 10, 2013 (GLOBE NEWSWIRE) --
about 45 days ago
Immunomedics Reports First Results of Labetuzumab-SN-38 in Colorectal Cancer
WASHINGTON, April 9, 2013 (GLOBE NEWSWIRE) --
about 46 days ago
Immunomedics Creates Novel Antibody-Cytokine Conjugates for Cancer Therapy
-- Preclinical Study Presented at 2013 Annual Meeting of the American Association for Cancer Research (AACR) --
Immunomedics Announces Clivatuzumab-Based Blood Test Can Differentiate Between Pancreatic Cancer and Chronic Pancreatitis
WASHINGTON, April 8, 2013 (GLOBE NEWSWIRE) --
about 47 days ago
Immunomedics Settles Finra Arbitration Proceedings Relating to Its Prior Investment in Certain Securities
MORRIS PLAINS, N.J., April 1, 2013 (GLOBE NEWSWIRE) --
about 53 days ago
Immunomedics Announces Presentations at the 2013 Annual Meeting of the American Association for Cancer Research
about 54 days ago
Immunomedics Announces Closing of Public Offering and Full Exercise of Overallotment Option by Underwriters
MORRIS PLAINS, N.J., Feb. 27, 2013 (GLOBE NEWSWIRE) --
about 86 days ago